Education - Webinar Upcoming

Enhancing patient safety: Addressing the potentially fatal consequences of undetected hemolysis at the point of care

  • Date
    Dec 18, 2025
  • Times
    1:00-2:00 pm ET
  • Location
    Live Webinar
  • CE Credits
    1.0 ACCENT
  • Duration
    1 hour
  • Recorded
    Available on demand through 12/31/2027
  • Price
    Free
  • Member Price
    Free

Description

Join us for an insightful webinar exploring patient safety risks and potentially fatal outcomes, due to undetected hemolysis at the point of care (POC). This webinar will cover patient cases where undetected hemolysis caused adverse patient outcomes, and will highlight how undetected hemolysis is exacerbated by insufficient awareness of blood gas testing limitations related to hemolysis. The importance of adopting solutions with integrated hemolysis detection to prevent these potential high-risk situations will be emphasized.

Through expert-led discussions and actionable frameworks, attendees will learn how to adopt and scale technologies that drive efficiency across diverse hospital environments. Whether you're navigating resource constraints or planning future growth, this session offers practical guidance to strengthen your lab’s impact and resilience.

Target audience

This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), point-of-care coordinators, fellows, residents, in-training individuals, and other laboratory professionals overseeing/conducting within this topic.

Learning objectives

At the end of this session, participants will be able to:

  • Describe the patient safety risks of undetected hemolysis in POC whole blood potassium testing
  • Identify challenges in clinical management to assess hemolysis at the POC
  • Recognize the need to adopt a solution that integrates hemolysis detection at the POC

Faculty

Speakers

Robert Cooper PhotoRobert Cooper MD, MBA, MPH
Associate Professor of Emergency Medicine
The Ohio State University Wexner Medical Center
Columbus, OH

 

Nam K Tran, PhD, HCLD (ABB), FADLM
Professor and Associate Dean of Biobanking
University of Pittsburgh, School of Medicine
Vice Chair of Biobanking
Medical Director, Point-of-Care Testing
Dept. of Pathology; UPMC
Pittsburgh, PA

 

Alan Wu PhotoAlan Wu, Ph.D., DABCC
Professor, University of California, San Francisco
Co-core Lab Director, Zuckerberg San Francisco General Hospital
San Francisco, CA  p style="clear:both;"

 

Disclosures and statement of independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported financial relationships:

  • Nam Tran, PhD, HCLD (ABB), FADLM
    • Honorarium: Nova Biomedical, Thermo, Diasorin
    • Consulting Fees: Roche, Radiometer
    • Committee and/or Advisory Board:  ADLM Board of Directors
  • Alan Wu, Ph.D., DABCC
    • Honorarium: Werfen
    • Consulting Fees: Werfen
    • Committee and/or Advisory Board: Werfen Advisory Board

The following faculty reported no financial relationships:

  • Robert Cooper, MD, MBA, MPH

Content validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation statement

This activity will be submitted for 1.0 ACCENT continuing education credit.

Successful completion statement

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

Sponsored and organized by